why choose us

First received: May 11, 2023

Clinical Trial: Assessment of Biomarker-Guided CNI Substitution In Kidney Transplantation

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Kidney Transplant

Study Type: INTERVENTIONAL


Official Title: Assessment of Biomarker-Guided Calcineurin Inhibitor (CNI) Substitution In Kidney Transplantation (RTB-015)

Brief Summary: 800 adult first time kidney transplant recipients will be enrolled in the Observational Study and followed to evaluate their Human Leukocyte Antigen (HLA)-DR/DQ molecular mismatch (mMM) score as a risk-stratifying prognostic biomarker.Six months after transplant the study will identify those who meet the eligibility criteria for the Nested Randomized Control Trial (RCT).300 eligible subjects will be randomized 2:1 to abatacept or Standard of care (SOC) in the randomization and followed for 18 months…

Read more